Search | IOVS | ARVO Journals

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Sustained oral delivery of ticagrelor (Brilinta) protects against retinal degeneration

Wennan Lu; Keith Campagno; Leif Carlsson; Claire H Mitchell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):49. doi:

Physiology and Pharmacology July 2019

Oral Delivery of the P2Y 12 Receptor Antagonist Ticagrelor Prevents Loss of Photoreceptors in an ABCA4 −/− Mouse Model of Retinal Degeneration

PDF

Wennan Lu; Keith E. Campagno; Huen-Yee Tso; Aurora Cenaj; Alan M. Laties; Leif G. Carlsson; Claire H. Mitchell
TAGS: mice, photoreceptors, retinal degeneration, ticagrelor, antagonists, administration, oral
Invest. Ophthalmol. Vis. Sci.. 2019; 60(8):3046-3053. doi: https://doi.org/10.1167/iovs.19-27241

ARVO Annual Meeting Abstract July 2018

Linking stressed astrocytes to activated microglia through purinergic signaling

Claire H Mitchell; Keith Campagno; Farraj Albalawi; Wennan Lu

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6034. doi:

ARVO Annual Meeting Abstract July 2018

IL-1β is released by retinal microglial cells in response to ATP and can damage retinal ganglion cells

Wennan Lu; Keith Campagno; Farraj Albalawi; Claire H Mitchell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3729. doi:

Advertisement